Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis Patients

Necrosis Factor ◽

Cytokine Profiling

Faculty Opinions recommendation of Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726749172.793568149 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2016.08.044 ◽

2017 ◽

Vol 15 (2) ◽

pp. 229-239.e5 ◽

Cited By ~ 74

Author(s):

Brian G. Feagan ◽

David T. Rubin ◽

Silvio Danese ◽

Severine Vermeire ◽

Brihad Abhyankar ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

Biologics in Crohn’s Disease and Ulcerative Colitis: Focus on Tumor Necrosis Factor Antagonists

Biologics in General Medicine ◽

10.1007/978-3-540-29018-6_12 ◽

2007 ◽

pp. 124-140

Author(s):

J. Salfeld ◽

P. Rutgeerts

Keyword(s):

Ulcerative Colitis ◽

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Tumor Necrosis ◽

Faculty Opinions recommendation of Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726749172.793549057 ◽

2018 ◽

Author(s):

Eduard Stange ◽

Jan Wehkamp

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

THE ASSOCIATION OF ANTI-TUMOR NECROSIS FACTOR THERAPY AND COLECTOMY WITH PANCREATIC ADENOCARCINOMA IN ULCERATIVE COLITIS: FINDINGS OF A NATIONWIDE EPIDEMIOLOGICAL STUDY

10.1055/s-0040-1704052 ◽

2020 ◽

Author(s):

MA Saleh ◽

M Alkhayyat ◽

C Rouphael ◽

E Mansoor ◽

C Roberto Simons-Linares ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Epidemiological Study ◽

Pancreatic Adenocarcinoma ◽

Tumor Necrosis ◽

Factor Therapy ◽

Faculty Opinions recommendation of A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160775.622184 ◽

2009 ◽

Author(s):

Cyrus Tamboli

Keyword(s):

Tumor Necrosis Factor ◽

Drug Administration ◽

Safety Assessment ◽

Tumor Necrosis ◽

Food And Drug Administration ◽

Faculty Opinions recommendation of Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732092122.793568144 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Inflammatory Bowel ◽

Ulcerative colitis-related postoperative enteritis treated with anti-tumor necrosis factor therapy: two case reports and a literature review

Clinical Journal of Gastroenterology ◽

10.1007/s12328-021-01485-5 ◽

2021 ◽

Author(s):

Fumiko Shimoda ◽

Masatake Kuroha ◽

Hirofumi Chiba ◽

Izuru Abe ◽

Kota Yano ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Literature Review ◽

Tumor Necrosis ◽

Case Reports ◽

Factor Therapy ◽

A case of ulcerative colitis complicating anti-tumor necrosis factor treatment for rheumatoid arthritis: successful treatment with leukocytapheresis

International Journal of Rheumatic Diseases ◽

10.1111/j.1756-185x.2012.01751.x ◽

2012 ◽

Vol 16 (1) ◽

pp. 107-109 ◽

Cited By ~ 3

Author(s):

Hideyuki Horikoshi ◽

Kunio Takada ◽

Tomoaki Higuchi ◽

Takahiro Yoshikawa ◽

Mitsuyo Matsumoto ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Successful Treatment ◽

Tumor Necrosis ◽

Necrosis Factor ◽

Tumor Necrosis Factor Treatment

24 REAL-WORLD COMPARISON OF TOFACITINIB VERSUS USTEKINUMAB AMONG ULCERATIVE COLITIS PATIENTS WITH PRIOR ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE: A PROPENSITY SCORE-ADJUSTED ANALYSIS

Gastroenterology ◽

10.1016/s0016-5085(21)00761-7 ◽

2021 ◽

Vol 160 (6) ◽

pp. S-5

Author(s):

Rahul S. Dalal ◽

Jennifer Mitri ◽

Hannah Goodrick ◽

Jessica R. Allegretti

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Propensity Score ◽

Treatment Failure ◽

Tumor Necrosis Factor Alpha ◽

Real World ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽